ArticleCureus2024
Relapsing Polychondritis Presenting With Hoarseness and Multisystem Involvement: A Diagnostic and Therapeutic Challenge.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Relapsing polychondritis (RP) is a rare autoimmune disorder characterized by recurrent inflammation of cartilaginous tissues throughout the body, particularly the ears, nose, eyes, joints, and the respiratory tract. We present a case of a 68-year-old female without previous comorbidities who presented with gradually progressive hoarseness of voice and inflammatory polyarthritis, nasal and ear involvement eventually leading to the diagnosis of RP with concurrent osteoporosis. The diagnosis was made based on Modified McAdam criteria, highlighting the significance of clinical evaluation in guiding diagnosis and treatment decisions. Treatment with intravenous cyclophosphamide and oral prednisolone resulted in significant improvement in symptoms and inflammatory markers. Osteoporosis was managed with intravenous zoledronic acid. This case underscores the importance of considering RP in the differential diagnosis of patients presenting with hoarseness of voice and multisystem involvement, even in the absence of histological confirmation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.